I was sitting in my clinic last week when a patient’s story struck me with an unexpected clarity about what I truly value in the founders I decide to back. It’s fascinating how seemingly unrelated fields like IVF and angel investing can offer insights into each other. This patient, let’s call her Meera, had been through the wringer. Multiple failed IVF cycles, a history of miscarriages, and yet, there she was—determined, hopeful, and fiercely committed to her dream of motherhood. Her journey made me think about the startups I’ve invested in and the founders who have impressed me the most.
In IVF, every patient is a story, unique and layered with personal challenges and aspirations. Meera’s story was one of resilience, a quality I find equally essential in the startup world. The tenacity she displayed is akin to the grit I admire in founders. It’s not just about having a brilliant idea or a flashy pitch deck; it’s about the relentless pursuit of a vision despite the odds. This realization made me rethink what I truly value in the founders I choose to support.
When I first ventured into angel investing, I was enamored by the allure of innovative ideas and the promise of lucrative returns. But over time, my perspective has evolved. Just as in medicine, where understanding a patient’s story can guide treatment decisions, in investing, a founder’s narrative can be a crucial determinant of my involvement. It’s the story behind the numbers that often makes all the difference.
Consider the case of a startup I once backed. The founders had a compelling product, but it was their personal journey that convinced me to invest. They had faced numerous setbacks, from regulatory hurdles to financial constraints, yet their resolve never wavered. This reminded me of the stories of resilience I often encounter in my practice. The parallels between these domains are striking. Both require an understanding of human behavior, a willingness to take risks, and the empathy to listen and adapt.
In both fields, the importance of a clear vision cannot be overstated. In IVF, a patient who can articulate her expectations and goals makes the treatment process more predictable and effective. Similarly, in investing, a founder who can succinctly explain their vision and strategy is more likely to succeed. If a founder’s narrative is muddled or inconsistent, it’s a red flag—just as it would be if a patient couldn’t communicate their symptoms or expectations clearly.
Trust and honesty are foundational in both my worlds. Just as I wouldn’t proceed with a treatment if I suspected a patient was withholding information, I wouldn’t invest in a startup if I felt the founder wasn’t being transparent. Trust is the cornerstone of any successful relationship, whether it’s between a doctor and patient or an investor and founder.
Another lesson I’ve learned is the importance of diversification. In medicine, relying on a single treatment option for every patient is impractical. Similarly, in investing, putting all my faith in one startup is risky. A diversified portfolio allows me to mitigate risk and increase the chances of supporting a successful venture. But it’s not just about spreading bets; it’s about finding those stories that resonate, much like identifying the right treatment plan for a patient’s unique circumstances.
In the early days of my investing journey, I was often swayed by startups that promised quick returns or had impressive pitch decks. But over time, I’ve come to appreciate the power of a good story. A compelling narrative can capture attention and drive action. It can make the difference between a startup that merely survives and one that thrives. I’ve seen this firsthand in the companies I’ve backed, where those with a strong vision and a well-articulated story have often outperformed those that focused solely on the product or market size.
Reflecting on these experiences, I’ve come to value the human element above all else. Whether it’s a patient determined to overcome infertility or a founder passionate about their startup, it’s the people and their stories that make these journeys worthwhile. As I continue to invest, I’ll carry with me the lessons learned from both sides of my professional life, always seeking to find those stories that resonate deeply and have the potential to change lives.
In the end, every investment, like every patient, is a new story waiting to unfold. And I’m privileged to play a part in that narrative. It’s a reminder that the hard path is often the most rewarding, and with each step, we get closer to realizing dreams, be it in the clinic or the boardroom.